01:18:52 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande


2023-11-09 Kvartalsrapport 2023-Q3
2023-08-17 Kvartalsrapport 2023-Q2
2023-05-26 Ordinarie utdelning CIRCA 0.00 NOK
2023-05-25 Årsstämma 2023
2023-05-11 Kvartalsrapport 2023-Q1
2023-02-16 Bokslutskommuniké 2022
2022-11-17 Kvartalsrapport 2022-Q3
2022-08-25 Kvartalsrapport 2022-Q2
2022-06-03 Ordinarie utdelning CIRCA 0.00 NOK
2022-06-02 Årsstämma 2022
2022-05-24 Kvartalsrapport 2022-Q1
2022-03-02 Bokslutskommuniké 2021
2021-11-25 Kvartalsrapport 2021-Q3
2021-08-26 Kvartalsrapport 2021-Q2
2021-06-17 Ordinarie utdelning CIRCA 0.00 NOK
2021-06-16 Årsstämma 2021
2021-05-27 Kvartalsrapport 2021-Q1
2021-03-02 Bokslutskommuniké 2020


ListaMERK Equities
Circa Group är verksamma inom bioteknik. Bolaget är en utvecklare av biokemikalier som vidare används för omvandling av avfallsmassa till diverse biokemiskt material. Tekniken används inom energisektorn vid olika produktionsprocesser. Bolaget grundades under 2006 och innehar störst verksamhet runtom den europeiska marknaden. Circa Group har sitt huvudkontor i Norge.
2021-06-26 00:00:12
OSLO, NORWAY - 25 June 2021. Reference is made to the press release from Circa
Group AS (the "Company") published today on 25 June 2021 regarding the
resolution to increase the share capital of the Company following the exercise
of 851,160 warrants by Moata Pty Ltd, a close associate of the Company's CEO,
Tony Duncan. 1,851,160 warrants were originally issued to the CEO, but
transferred to Moata Pty Ltd in connection with the exercise.

In accordance with the terms of the warrants, the price for the shares issued
following exercise of the 851,160 warrants was NOK 1 per share, in total NOK

Following issuance of the shares, Moata Pty Ltd owns 1,000,000 shares in the
Company, equal to approximately 0.82% of the outstanding existing shares, and
holds 1,000,000 warrants. Tony Duncan owns 5,480,000 shares in the Company,
equal to approximately 4.50% of the outstanding existing shares.

In addition, another close associate of Tony Duncan, Penelope Duncan, owns
280,000 shares in the Company, equal to approximately 0.23% of the outstanding
existing shares.

Please refer to the attached notifications of trading for further details.

About Circa
Established in 2006, Circa Group converts waste, non-food biomass into advanced
bio-based chemicals with its proprietary FuracellTM process. Its developing
product portfolio includes flavours, biopolymers, and bio-solvents including
CyreneTM, an alternative to traditional polar aprotic solvents, which is produced
in one step from platform biomolecule Levoglucosenone. By creating renewable
chemicals from cellulose, Circa is extracting value from non-food, waste biomass
and addressing a gap in the market by providing bio-based alternatives
contributing to a more circular economy. In March 2021, Circa Group successfully
listed on the Euronext Growth Market in Oslo, stock symbol CIRCA.

Media Contact
Kathryn Sheridan
Sustainability Consult